Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 22, 2018 21:45 ET | Source: Precipio, Inc.

Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results

Provides participation details for Thursday, August 23 call NEW HAVEN, Conn., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), wishes to remind...
August 17, 2018 07:37 ET | Source: Precipio, Inc.

Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Conference call with management to be held Thursday August 23, 2018 at 09:00 Eastern Time NEW HAVEN, Conn., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc....
August 09, 2018 07:37 ET | Source: Precipio, Inc.

Precipio Appoints New Board Member to Replace Departing Director

Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics and healthcare companies NEW HAVEN, Conn., Aug. 09, 2018 (GLOBE NEWSWIRE) --...
July 18, 2018 07:37 ET | Source: Precipio, Inc.

Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results

Third consecutive quarter of triple-digit YoY Quarterly growth NEW HAVEN, Conn., July 18, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today...
June 26, 2018 08:00 ET | Source: Precipio, Inc.

Precipio and Nucleai Partner to Develop Artificial Intelligence-Powered Hemepath Solution

System will support Hematopathologists in accurately identifying abnormalities to ensure diagnostic accuracy NEW HAVEN, Conn., June 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
June 19, 2018 07:38 ET | Source: Precipio, Inc.

Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology

Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, Conn., June 19, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO),...
June 15, 2018 20:11 ET | Source: Precipio, Inc.

Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders

NEW HAVEN, Conn., June 15, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that the Company’s 2018 Annual Meeting of Shareholders, originally...
June 14, 2018 12:19 ET | Source: Precipio, Inc.

Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018

NEW HAVEN, Conn., June 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the...
June 12, 2018 08:00 ET | Source: Precipio, Inc.

Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018

NEW HAVEN, Conn., June 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the...
June 06, 2018 07:38 ET | Source: Precipio, Inc.

Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology

NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR...